^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    lacnotuzumab (MCS110)

    i
    Other names: MCS110, MCS 110, MCS-110
    Company:
    Novartis
    Drug class:
    CSF-1 inhibitor
    Related drugs: